Sakai T, Shiraki K, Deguchi M, Itoh N, Konishi T, Takase K, Nakano T
Department of Internal Medicine, Mie Prefectural General Medical Center, Mie, Japan.
Hepatogastroenterology. 2001 Sep-Oct;48(41):1464-6.
Hepatocellular carcinoma may manifest various paraneoplastic syndromes. There are some reports describing hematological change due to hepatocellular carcinoma. However, there have been no reports on hepatocellular carcinoma accompanied by hemophagocytic syndrome. We report here for the first time a 51-year-old man with a liver tumor and pancytopenia. Since the patient had showed a strong hemorrhagic diathesis because of thrombocytopenia, we treated him with blood transfusion, but there was no response. Thereafter, we administered the anticancer agents thinking that the hematological change was due to the liver tumor. Though a slight curative effect was obtained, we had to discontinue the treatment because the patient complained of severe side effects. Finally, the patient died of acute cholangitis. Although we could not determine the cause of the pancytopenia before he died, autopsy findings indicated that hemophagocytic syndrome had occurred. Hemophagocytic syndrome related to a solid tumor very rarely occurs. However, when malignant tumor is accompanied by pancytopenia, hemophagocytic syndrome should be considered.
肝细胞癌可能表现出各种副肿瘤综合征。有一些报告描述了肝细胞癌引起的血液学变化。然而,尚无关于伴有噬血细胞综合征的肝细胞癌的报告。我们在此首次报告一名51岁患有肝肿瘤和全血细胞减少症的男性。由于患者因血小板减少而表现出强烈的出血倾向,我们对其进行了输血治疗,但没有效果。此后,我们认为血液学变化是由肝肿瘤引起的,于是给予了抗癌药物。虽然获得了轻微的疗效,但由于患者抱怨有严重的副作用,我们不得不停止治疗。最后,患者死于急性胆管炎。虽然在他去世前我们无法确定全血细胞减少的原因,但尸检结果表明发生了噬血细胞综合征。与实体瘤相关的噬血细胞综合征非常罕见。然而,当恶性肿瘤伴有全血细胞减少时,应考虑噬血细胞综合征。